Recent advances in vaccine and immunotherapy for COVID-19

Ali A. Rabaan; Shamsah H. Al-Ahmed; Ranjit Sah; Jaffar A. Al-Tawfiq; Ayman M. Al-Qaaneh; Lamiaa H. Al-Jamea; Alexander Woodman; Manaf Al-Qahtani; Shafiul Haque; Harapan Harapan; D. Katterine Bonilla-Aldana; Pavan Kumar; Kuldeep Dhama; Alfonso J. Rodriguez-Morales

doi:10.1080/21645515.2020.1825896

Recent advances in vaccine and immunotherapy for COVID-19

Ali A. Rabaan
, Shamsah H. Al-Ahmed
, Ranjit Sah
, Jaffar A. Al-Tawfiq
, Ayman M. Al-Qaaneh
, Lamiaa H. Al-Jamea
, Alexander Woodman
, Manaf Al-Qahtani
, Shafiul Haque
, Harapan Harapan
, D. Katterine Bonilla-Aldana
, Pavan Kumar
, Kuldeep Dhama
, Alfonso J. Rodriguez-Morales

Johns Hopkins Aramco Healthcare
Qatif Central Hospital
Tribhuvan University
Indiana University Bloomington
Johns Hopkins University
Imam Abdulrahman Bin Faisal University
Prince Sultan Military College of Health Sciences - Al Dhahran
Bahrain Defence Force Royal Medical Services
Royal College of Surgeons in Ireland Medical University of Bahrain
Jazan University
Universitas Syiah Kuala
Fundación Universitaria Autónoma de las Américas
Universidad Tecnológica de Pereira
Rani Lakshmi Bai Central Agricultural University
Indian Veterinary Research Institute

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.

Original language	English
Pages (from-to)	3011-3022
Number of pages	12
Journal	Human Vaccines and Immunotherapeutics
Volume	16
Issue number	12
DOIs	https://doi.org/10.1080/21645515.2020.1825896
State	Published - 2020
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

COVID-19
SARS-CoV-2
immunotherapeutics
pandemic
vaccine

Access to Document

10.1080/21645515.2020.1825896

Cite this

Rabaan, A. A., Al-Ahmed, S. H., Sah, R., Al-Tawfiq, J. A., Al-Qaaneh, A. M., Al-Jamea, L. H., Woodman, A., Al-Qahtani, M., Haque, S., Harapan, H., Bonilla-Aldana, D. K., Kumar, P., Dhama, K., & Rodriguez-Morales, A. J. (2020). Recent advances in vaccine and immunotherapy for COVID-19. Human Vaccines and Immunotherapeutics, 16(12), 3011-3022. https://doi.org/10.1080/21645515.2020.1825896

@article{7ce19c543d1a4d17a8ab68d6eee6a352,

title = "Recent advances in vaccine and immunotherapy for COVID-19",

abstract = "The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.",

keywords = "COVID-19, SARS-CoV-2, immunotherapeutics, pandemic, vaccine",

author = "Rabaan, \{Ali A.\} and Al-Ahmed, \{Shamsah H.\} and Ranjit Sah and Al-Tawfiq, \{Jaffar A.\} and Al-Qaaneh, \{Ayman M.\} and Al-Jamea, \{Lamiaa H.\} and Alexander Woodman and Manaf Al-Qahtani and Shafiul Haque and Harapan Harapan and Bonilla-Aldana, \{D. Katterine\} and Pavan Kumar and Kuldeep Dhama and Rodriguez-Morales, \{Alfonso J.\}",

note = "Publisher Copyright: {\textcopyright} 2020 The Author(s). Published with license by Taylor \& Francis Group, LLC.",

year = "2020",

doi = "10.1080/21645515.2020.1825896",

language = "English",

volume = "16",

pages = "3011--3022",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Taylor and Francis Ltd.",

number = "12",

}

Rabaan, AA, Al-Ahmed, SH, Sah, R, Al-Tawfiq, JA, Al-Qaaneh, AM, Al-Jamea, LH, Woodman, A, Al-Qahtani, M, Haque, S, Harapan, H, Bonilla-Aldana, DK, Kumar, P, Dhama, K & Rodriguez-Morales, AJ 2020, 'Recent advances in vaccine and immunotherapy for COVID-19', Human Vaccines and Immunotherapeutics, vol. 16, no. 12, pp. 3011-3022. https://doi.org/10.1080/21645515.2020.1825896

TY - JOUR

T1 - Recent advances in vaccine and immunotherapy for COVID-19

AU - Rabaan, Ali A.

AU - Al-Ahmed, Shamsah H.

AU - Sah, Ranjit

AU - Al-Tawfiq, Jaffar A.

AU - Al-Qaaneh, Ayman M.

AU - Al-Jamea, Lamiaa H.

AU - Woodman, Alexander

AU - Al-Qahtani, Manaf

AU - Haque, Shafiul

AU - Harapan, Harapan

AU - Bonilla-Aldana, D. Katterine

AU - Kumar, Pavan

AU - Dhama, Kuldeep

AU - Rodriguez-Morales, Alfonso J.

PY - 2020

Y1 - 2020

N2 - The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.

AB - The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.

KW - COVID-19

KW - SARS-CoV-2

KW - immunotherapeutics

KW - pandemic

KW - vaccine

UR - https://www.scopus.com/pages/publications/85095809734

U2 - 10.1080/21645515.2020.1825896

DO - 10.1080/21645515.2020.1825896

M3 - Article

C2 - 33156739

AN - SCOPUS:85095809734

SN - 2164-5515

VL - 16

SP - 3011

EP - 3022

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 12

ER -

Recent advances in vaccine and immunotherapy for COVID-19

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this